WallStreetZenWallStreetZen

NYSE: LLY
ELI LILLY & CO Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LLY past earnings growth

How has LLY's earnings growth performed historically?
Company
0.75%
Industry
97.28%
Market
92.76%
LLY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LLY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LLY's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LLY past revenue growth

How has LLY's revenue growth performed historically?
Company
15.06%
Industry
24.91%
Market
51.15%
LLY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LLY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LLY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LLY earnings and revenue history

Current Revenue
$29.3B
Current Earnings
$6.1B
Current Profit Margin
20.9%
LLY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

LLY Return on Equity

Current Company
75.4%
Current Industry
42%
Current Market
38.4%
LLY's Return on Equity (75.4%)... subscribe to Premium to read more.
High Return on Equity Performance

LLY Return on Assets

Current Company
12.8%
Current Industry
10.4%
LLY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LLY Return on Capital Employed

Current Company
20.08%
Current Industry
15.6%
LLY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LLY vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LLY$29.32B$8.37B$6.13B+6.32%+26.58%
PFE$92.37B$32.34B$24.97B+11.92%+29.91%
ABBV$56.73B$24.70B$12.48B+16.69%+12.44%
MRK$53.98B$19.42B$14.18B+6.21%+28.84%
AZN$41.49B$7.05B-$1.06B+13.23%N/A
View Top General Drug Manufacturer Stocks

ELI LILLY & Earnings & Revenue FAQ

What were LLY's earnings last quarter?

On Invalid Date, ELI LILLY & (NYSE: LLY) reported Q1 2022 earnings per share (EPS) of $2.11, up 41.61% year over year. Total ELI LILLY & earnings for the quarter were $1.90 billion. In the same quarter last year, ELI LILLY &'s earnings per share (EPS) was $1.49.

What was LLY's earnings growth in the past year?

As of Q2 2022, ELI LILLY &'s earnings has grown 0.75% year over year. This is 96.54 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 97.28%. ELI LILLY &'s earnings in the past year totalled $6.13 billion.

What was LLY's revenue last quarter?

On Invalid Date, ELI LILLY & (NYSE: LLY) reported Q1 2022 revenue of $7.81 billion up 14.76% year over year. In the same quarter last year, ELI LILLY &'s revenue was $6.81 billion.

What was LLY's revenue growth in the past year?

As of Q2 2022, ELI LILLY &'s revenue has grown 15.06% year over year. This is 9.85 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.91%. ELI LILLY &'s revenue in the past year totalled $29.32 billion.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.